Select Medical (SEM) to Release Q4 and Full Year 2025 Financial Results on February 19, 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 21 2026
0mins
Should l Buy SEM?
Source: PRnewswire
- Earnings Release Schedule: Select Medical will release its Q4 and full year 2025 financial results after market close on February 19, 2026, providing investors with critical financial data and operational performance insights.
- Conference Call Details: The company will host a conference call on February 20, 2026, at 9:00 AM ET to discuss the financial results in detail and offer an opportunity for investor questions.
- Business Scale Overview: As of December 31, 2025, Select Medical operates 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across the U.S., highlighting its extensive footprint and market leadership in the healthcare sector.
- Diverse Business Structure: Select Medical's reportable segments include critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation, showcasing its robust capabilities and adaptability in the diversified healthcare services market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SEM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SEM
Wall Street analysts forecast SEM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SEM is 18.75 USD with a low forecast of 17.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 15.470
Low
17.00
Averages
18.75
High
21.00
Current: 15.470
Low
17.00
Averages
18.75
High
21.00
About SEM
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Select Medical (SEM) to Release Q4 and Full Year 2025 Financial Results on February 19, 2026
- Earnings Release Schedule: Select Medical will release its Q4 and full year 2025 financial results after market close on February 19, 2026, providing investors with critical financial data and operational performance insights.
- Conference Call Details: The company will host a conference call on February 20, 2026, at 9:00 AM ET to discuss the financial results in detail and offer an opportunity for investor questions.
- Business Scale Overview: As of December 31, 2025, Select Medical operates 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across the U.S., highlighting its extensive footprint and market leadership in the healthcare sector.
- Diverse Business Structure: Select Medical's reportable segments include critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation, showcasing its robust capabilities and adaptability in the diversified healthcare services market.
See More
Select Medical Holdings Under Investigation for Potential Securities Violations
- Investigation Launched: Kaskela Law LLC has initiated an investigation into Select Medical Holdings Corporation to determine whether the company and its officers violated securities laws or breached fiduciary duties, potentially impacting shareholder rights.
- Shareholder Rights Protection: This investigation focuses on recent corporate actions by Select Medical, encouraging shareholders to contact the law firm to understand their legal rights and options, highlighting concerns over corporate governance.
- Legal Consultation Channels: Kaskela Law LLC offers multiple contact methods, including phone and email, aimed at providing necessary legal support to shareholders to ensure their rights in potential legal issues are protected.
- Investor Representation: The law firm specializes in securities fraud, corporate governance, and merger & acquisition litigation, indicating its commitment to providing robust legal support for investors and safeguarding shareholder interests.
See More
Select Medical Holdings Shares Surge 12% Following Take-Private Proposal from Executive Chairman
Stock Performance: Select Medical Holdings Corporation (SEM) shares rose 12.35% to $15.74 following a buyout proposal from Executive Chairman Robert A. Ortenzio, who offered to acquire shares for $16.00 to $16.20 in cash.
Proposal Details: Ortenzio's acquisition proposal was filed publicly on November 24, 2025, and the board's independent members are currently consulting advisors to evaluate the offer.
Market Reaction: The announcement led to unusually high trading volume for SEM as investors reacted to the potential buyout scenario.
Cautionary Note: The company has stated that there is no guarantee the deal will proceed and will keep shareholders updated as necessary.
See More
SEM Surpasses Important Moving Average Threshold
- 52 Week Range: SEM's stock has a 52-week low of $11.65 and a high of $21.36, with the last trade recorded at $16.29.
- Dividend Stocks: There is a mention of other dividend stocks that have recently crossed above their 200-day moving average.
- Author's Views: The opinions expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
- Market Analysis: The information provided includes a brief analysis of SEM's stock performance within the context of the market.
See More
Select Medical co-founder offers to acquire all shares and privatize the company.
Take-Private Proposal: Select Medical (SEM) received a non-binding proposal from executive chairman Robert A. Ortenzio to acquire all shares for $16.00 to $16.20 each.
Board Review: The disinterested members of SEM's Board of Directors are evaluating the proposal with advisors to ensure the best interests of the company and its shareholders.
Stock Price Reaction: Following the announcement, SEM's stock price increased by approximately 7% during after-market trading.
Financial Performance: Select Medical reported a Q3 2025 revenue target of $5.3B–$5.5B, with a non-GAAP EPS of $0.23, exceeding expectations.
See More
Select Medical (SEM) Receives $16.00 to $16.20 Acquisition Proposal from Chairman
- Acquisition Proposal: Select Medical's Executive Chairman Robert A. Ortenzio has proposed a cash acquisition offer ranging from $16.00 to $16.20 per share, indicating a recognition of the company's value and potentially influencing shareholder investment decisions.
- Board Review: The Board of Directors of Select Medical is carefully reviewing the proposal in consultation with advisors, ensuring actions align with the best interests of the company and its shareholders, reflecting transparency and accountability in corporate governance.
- Market Reaction: The public announcement of the proposal may trigger increased market attention on Select Medical's stock, prompting investors to reassess their positions in healthcare sector equities.
- Future Uncertainty: Despite the proposal being made, Select Medical has not guaranteed that a transaction will occur, leaving the outcome uncertain, which could affect investor confidence and market expectations.
See More
Select Medical (SEM) to Release Q4 and Full Year 2025 Financial Results on February 19, 2026
- Earnings Release Schedule: Select Medical will release its Q4 and full year 2025 financial results after market close on February 19, 2026, providing investors with critical financial data and operational performance insights.
- Conference Call Details: The company will host a conference call on February 20, 2026, at 9:00 AM ET to discuss the financial results in detail and offer an opportunity for investor questions.
- Business Scale Overview: As of December 31, 2025, Select Medical operates 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across the U.S., highlighting its extensive footprint and market leadership in the healthcare sector.
- Diverse Business Structure: Select Medical's reportable segments include critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation, showcasing its robust capabilities and adaptability in the diversified healthcare services market.
See More
Select Medical Holdings Under Investigation for Potential Securities Violations
- Investigation Launched: Kaskela Law LLC has initiated an investigation into Select Medical Holdings Corporation to determine whether the company and its officers violated securities laws or breached fiduciary duties, potentially impacting shareholder rights.
- Shareholder Rights Protection: This investigation focuses on recent corporate actions by Select Medical, encouraging shareholders to contact the law firm to understand their legal rights and options, highlighting concerns over corporate governance.
- Legal Consultation Channels: Kaskela Law LLC offers multiple contact methods, including phone and email, aimed at providing necessary legal support to shareholders to ensure their rights in potential legal issues are protected.
- Investor Representation: The law firm specializes in securities fraud, corporate governance, and merger & acquisition litigation, indicating its commitment to providing robust legal support for investors and safeguarding shareholder interests.
See More
Select Medical Holdings Shares Surge 12% Following Take-Private Proposal from Executive Chairman
Stock Performance: Select Medical Holdings Corporation (SEM) shares rose 12.35% to $15.74 following a buyout proposal from Executive Chairman Robert A. Ortenzio, who offered to acquire shares for $16.00 to $16.20 in cash.
Proposal Details: Ortenzio's acquisition proposal was filed publicly on November 24, 2025, and the board's independent members are currently consulting advisors to evaluate the offer.
Market Reaction: The announcement led to unusually high trading volume for SEM as investors reacted to the potential buyout scenario.
Cautionary Note: The company has stated that there is no guarantee the deal will proceed and will keep shareholders updated as necessary.
See More
SEM Surpasses Important Moving Average Threshold
- 52 Week Range: SEM's stock has a 52-week low of $11.65 and a high of $21.36, with the last trade recorded at $16.29.
- Dividend Stocks: There is a mention of other dividend stocks that have recently crossed above their 200-day moving average.
- Author's Views: The opinions expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
- Market Analysis: The information provided includes a brief analysis of SEM's stock performance within the context of the market.
See More
Select Medical co-founder offers to acquire all shares and privatize the company.
Take-Private Proposal: Select Medical (SEM) received a non-binding proposal from executive chairman Robert A. Ortenzio to acquire all shares for $16.00 to $16.20 each.
Board Review: The disinterested members of SEM's Board of Directors are evaluating the proposal with advisors to ensure the best interests of the company and its shareholders.
Stock Price Reaction: Following the announcement, SEM's stock price increased by approximately 7% during after-market trading.
Financial Performance: Select Medical reported a Q3 2025 revenue target of $5.3B–$5.5B, with a non-GAAP EPS of $0.23, exceeding expectations.
See More
Select Medical (SEM) Receives $16.00 to $16.20 Acquisition Proposal from Chairman
- Acquisition Proposal: Select Medical's Executive Chairman Robert A. Ortenzio has proposed a cash acquisition offer ranging from $16.00 to $16.20 per share, indicating a recognition of the company's value and potentially influencing shareholder investment decisions.
- Board Review: The Board of Directors of Select Medical is carefully reviewing the proposal in consultation with advisors, ensuring actions align with the best interests of the company and its shareholders, reflecting transparency and accountability in corporate governance.
- Market Reaction: The public announcement of the proposal may trigger increased market attention on Select Medical's stock, prompting investors to reassess their positions in healthcare sector equities.
- Future Uncertainty: Despite the proposal being made, Select Medical has not guaranteed that a transaction will occur, leaving the outcome uncertain, which could affect investor confidence and market expectations.
See More
